Clinical Trial Update: A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the safety and efficacy of inhaled tobramycin in young children with cystic fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• TOBI (Tobramycin inhalation solution)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED